Publications
228 publications since 2008, 81 of them as first or senior author: 169 reports of original research and 59 reviews, chapters, editorials and guidelines.
29,891 citations, h-index 64, i10-index 168. Google Scholar, 2026-11-03
Eleven papers that define the lab's research.
- 2026
Comprehensive mechanistic review reframing uPAR/suPAR as compartmentalized signaling system in CKM syndrome: membrane uPAR drives local inflammation/remodeling, soluble suPAR mediates remote organ injury via αvβ3-integrin/RAGE activation
- 2024
AHA scientific statement providing comprehensive guidance on cardiovascular evaluation, risk stratification, and management across all phases of hematopoietic stem cell transplantation from pretransplant assessment through long-term survivorship
- 2023
The 100-day and 5-year cumulative incidence of CV events after HSCT were 4.1% and 13.9%; allogeneic recipients had higher incidence of long-term CV events compared to autologous recipients (16.4% vs 12.1%).
- 2023
D2D3 uPAR fragment impairs pancreatic beta-cell function and causes glomerular injury in transgenic mice; anti-uPAR antibody restores beta-cell mass and function.
- 2023
Thymic epithelial tumors were associated with 18-fold higher ICI-myocarditis risk, earlier onset, higher mortality (64% vs 23% at 30 days), and more severe myotoxicities compared to other cancers.
- 2022
ICI myocarditis incidence was 1.0%; CPK elevation was sensitive (99%) for myocarditis and predicted all-cause mortality independent of cardiac biomarkers.
- 2022
suPAR levels predict coronary calcification and CVD events; GWAS identified PLAUR rs4760 variant causing elevated suPAR; Mendelian randomization shows causality; suPAR-transgenic mice develop larger atherosclerotic plaques via proinflammatory monocyte priming
- 2020
Admission suPAR levels predicted AKI and dialysis need in 352 COVID-19 patients; highest tertile had 9.15-fold increased AKI odds and 22.86-fold dialysis odds, independent of inflammatory markers.
- 2020
Highest suPAR quartile associated with 2.66-fold higher odds of AKI; suPAR overexpression in mice worsened contrast-induced AKI; anti-uPAR antibody attenuated kidney injury, establishing suPAR as biomarker and therapeutic target
- 2017
APOL1 G1/G2 risk variants conferred CKD risk only when suPAR elevated; mechanistically, APOL1 variants bind suPAR-activated αvβ3 integrin with higher affinity, causing podocyte injury.
- 2015
Higher suPAR predicted 3.1-fold increased incident CKD risk and greater eGFR decline, with annual decline of -4.2 ml/min/1.73m² in highest quartile versus -0.9 in lowest.
Everything, 2008 to 2026.
Showing all 228 publications.
| Year | Inflammation & Organ Injury | Cardio-Oncology | Other |
|---|---|---|---|
| 2008 | 0 | 0 | 1 |
| 2011 | 2 | 0 | 0 |
| 2013 | 1 | 0 | 5 |
| 2014 | 5 | 0 | 7 |
| 2015 | 6 | 0 | 8 |
| 2016 | 10 | 0 | 2 |
| 2017 | 13 | 0 | 7 |
| 2018 | 6 | 2 | 4 |
| 2019 | 4 | 5 | 2 |
| 2020 | 14 | 4 | 0 |
| 2021 | 20 | 7 | 1 |
| 2022 | 19 | 6 | 0 |
| 2023 | 11 | 8 | 0 |
| 2024 | 10 | 9 | 1 |
| 2025 | 8 | 4 | 0 |
| 2026 | 9 | 7 | 0 |
202616 papers
-
Atrial Fibrillation After Stem Cell Transplantation: Sentinel of Systemic Vulnerability
-
Combination cardiometabolic therapy in type 2 diabetes: optimizing SGLT2 inhibitor and GLP-1 receptor agonist use
-
Comparative Risk of Cardiovascular Hospitalization With Immune Checkpoint Inhibitors Versus Chemotherapy
-
Effectiveness and Safety of Immunotherapy in Advanced NSCLC with Pericardial Effusions: A Global Retrospective Multicenter Study
-
High-Sensitivity Cardiac Troponin T and I Discordance in Patients Receiving Immune Checkpoint Inhibitors
-
Immune checkpoint inhibitor-associated myocarditis: a novel risk score
-
Long-term ambient air pollution is not associated with circulating soluble urokinase plasminogen activator receptor
-
Personalized Antithrombotic Therapy After Percutaneous Coronary Intervention: A Systematic Review of Risk-Stratified Approaches
-
Practical considerations in the management of patients with atrial fibrillation/flutter and hematologic malignancies
-
SGLT2 inhibitors and cardiovascular outcomes in patients with diabetes following hematopoietic stem cell transplantation: A propensity-matched cohort study
-
Sotagliflozin, suPAR, and Cardiovascular Outcomes in Patients With Diabetes and Heart Failure: A SOLOIST-WHF Ancillary Study
-
suPAR Identifies Treatment-Resistant Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes With Coronary Artery Disease: An Ancillary Analysis of BARI 2D
-
The role of suPAR and related proteins in kidney, heart diseases, and diabetes
-
uPAR/suPAR Signaling and Organ Crosstalk in Cardiovascular-Kidney-Metabolic Syndrome
-
Urinary Metals, Soluble Urokinase Plasminogen Activator Receptor, and Outcomes in the Multi-Ethnic Study of Atherosclerosis
-
Viral-specific induction of cellular and soluble urokinase plasminogen activator receptor (suPAR) expression
202512 papers
-
A Phase II Multicenter Trial of Trabectedin in Combination with Olaparib in Patients with Advanced Unresectable or Metastatic Sarcoma
-
ACEi and ARBs as Primary Prevention of Cancer Therapy-Related Cardiomyopathy in Patients Undergoing Chemotherapy with Anthracyclines: A Systematic Review and Meta-Analysis
-
Achievement of LDL-C <55 mg/dL among US adults: Findings from the cvMOBIUS2 registry
-
Benefits of Tadalafil and Sildenafil on Mortality, Cardiovascular Disease, and Dementia
-
Cardiovascular and Thromboembolic Events in Children and Adults With Glomerular Disease: Findings From the Cure GlomeruloNephropathy (CureGN) Network
-
Factors Associated With the Recovery of Left Ventricular Ejection Fraction in Patients With Anthracycline-Induced Left Ventricular Dysfunction
-
Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction
-
Pregnant hospitalized COVID-19 patients: disease, delivery, maternal and fetal outcomes
-
Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels and Long-Term Cardiovascular Outcomes in Survivors of Breast Cancer: A UK Biobank Study
-
Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary study
-
Soluble urokinase plasminogen activator receptor for risk stratification from undifferentiated acute chest pain through to convalescence after acute coronary syndromes
-
The Reply
202420 papers
-
Biomarkers of chronic inflammation and cognitive decline: A prospective observational study
-
Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association
-
Cardiovascular mortality trends and disparities in U.S. breast cancer patients, 1999-2020: a population-based retrospective study
-
Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE-BMT Risk Score
-
Incidence of Immune Checkpoint Inhibitor-Induced Myocarditis During the COVID-19 Pandemic
-
Increased myositis and possible myocarditis in melanoma patients treated with immune checkpoint inhibitors in the COVID-19 era
-
Inflammatory Markers and Measures of Cardiovascular Autonomic Neuropathy in Type 1 Diabetes
-
Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study
-
Monocyte-Mediated Thrombosis Linked to Circulating Tissue Factor and Immune Paralysis in COVID-19
-
Obesity, Inflammation, and Clinical Outcomes in COVID-19: A Multicenter Prospective Cohort Study
-
Particulate Matter 2.5 Pollution Impact on Comorbid Cancer and Cardiovascular Disease Mortality in the U.S
-
Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity
-
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
-
Residential Address Amplifies Health Disparities and Risk of Infection in Individuals With Diabetic Foot Ulcers
-
Response by Goonewardena et al to Letter Regarding Article, 'Monocyte-Mediated Thrombosis Linked to Circulating Tissue Factor and Immune Paralysis in COVID-19'
-
SGLT2i and Primary Prevention of Cancer Therapy-Related Cardiac Dysfunction in Patients With Diabetes
-
Statin Therapy, Inflammation, and Outcomes in Patients Hospitalized for COVID-19: A Prospective Multicenter Cohort Study
-
SuPAR, Biomarkers of Inflammation, and Severe Outcomes in Patients Hospitalized for COVID-19: The International Study of Inflammation in COVID-19
-
Survival Characteristics of Older Patients Hospitalized With COVID-19: Insights From the American Heart Association COVID-19 Cardiovascular Disease Registry
-
The authors reply
202319 papers
-
Aggregate Clinical and Biomarker-Based Model Predicts Adverse Outcomes in Patients With Coronary Artery Disease
-
Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
-
Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis
-
Cardiovascular Considerations in Patients Undergoing Hematopoietic Stem Cell Transplantation
-
Cardiovascular Events After Hematopoietic Stem Cell Transplant: Incidence and Risk Factors
-
COVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease
-
Evolution of Care and Outcomes Across Surges in Hospitalized Patients with Coronavirus Disease 2019
-
Immune Activation Mediates the Association of Advanced Hepatic Fibrosis With Adverse Outcomes in Patients With Coronary Artery Disease
-
Metastatic melanoma of the heart: Retrospective cohort study and systematic review of prevalence, clinical characteristics, and outcomes
-
Prospective Cohort Study of Soluble Urokinase Plasminogen Activation Receptor and Cardiovascular Events in Patients With CKD
-
Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis
-
Role of Soluble Urokinase-Type Plasminogen Activator Receptor in Cardiovascular Disease
-
Site-level variability in the processes of care and outcomes over time among patients with COVID-19 and myocardial injury: Insights from the American Heart Association's COVID-19 Cardiovascular Disease Registry
-
Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart Failure
-
suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury
-
SuPAR mediates viral response proteinuria by rapidly changing podocyte function
-
The D2D3 form of uPAR acts as an immunotoxin and may cause diabetes and kidney disease
-
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis
-
Timing of invasive mechanical ventilation and death in critically ill adults with COVID-19: A multicenter cohort study
202225 papers
-
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
-
Assay-related differences in SuPAR levels: implications for measurement and data interpretation
-
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis
-
Association of Surge Conditions with Mortality Among Critically Ill Patients with COVID-19
-
Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis
-
Biomarkers for monitoring and prevention in cancer/heart disease: Traditional and innovative perspectives
-
Chronic Kidney Disease Is a Risk Enhancer for Cardiovascular Diseases
-
Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant
-
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry
-
COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study
-
Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort Study
-
Efficacy of COVID-19 Vaccines in Patients Taking Immunosuppressants
-
Hispanic ethnicity and mortality among critically ill patients with COVID-19
-
Impact of Social Vulnerability on Comorbid Cancer and Cardiovascular Disease Mortality in the United States
-
Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis
-
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19
-
Kidney Recovery and Death in Critically Ill Patients With COVID-19-Associated Acute Kidney Injury Treated With Dialysis: The STOP-COVID Cohort Study
-
Modulation of the Association Between Age and Death by Risk Factor Burden in Critically Ill Patients With COVID-19
-
Molecular consequences of SARS-CoV-2 liver tropism
-
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19
-
Right Ventricular Dysfunction in Critically Ill Patients With COVID-19
-
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19
-
Soluble Urokinase Receptor and Mortality in Kidney Transplant Recipients
-
The Management of Patients with Heart Failure and Diabetes
-
The Role of Tissue Biopsy in the Management of Immune Checkpoint Inhibitor Toxicity
202128 papers
-
A Systematic Review of the Incidence and Outcomes of In-Hospital Cardiac Arrests in Patients With Coronavirus Disease 2019
-
AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19
-
Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19
-
Application of regularized regression to identify novel predictors of mortality in a cohort of hemodialysis patients
-
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
-
Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation
-
Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States
-
Circulating Osteopontin Levels and Outcomes in Patients Hospitalized for COVID-19
-
Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review
-
d-dimer and Death in Critically Ill Patients With Coronavirus Disease 2019
-
Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin
-
Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis
-
Exposure and risk factors for COVID-19 and the impact of staying home on Michigan residents
-
Extracorporeal membrane oxygenation in patients with severe respiratory failure from COVID-19
-
Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors: A Scientific Statement From the American Heart Association
-
Hospital-Level Variation in Death for Critically Ill Patients with COVID-19
-
Identification of Distinct Clinical Subphenotypes in Critically Ill Patients With COVID-19
-
Impact of Cancer and Cardiovascular Disease on In-Hospital Outcomes of COVID-19 Patients: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry
-
Impact of cancer and cardiovascular disease on in-hospital outcomes of COVID-19 patients: results from the american heart association COVID-19 cardiovascular disease registry
-
Incidence, Predictors, and Outcomes of In-Hospital Cardiac Arrest in COVID-19 Patients Admitted to Intensive and Non-Intensive Care Units: Insights From the AHA COVID-19 CVD Registry
-
Machine Learning Prediction of Death in Critically Ill Patients With Coronavirus Disease 2019
-
Management of Patients With Giant Cell Myocarditis: JACC Review Topic of the Week
-
New perspectives in cardio-oncology
-
Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US
-
Performance of crisis standards of care guidelines in a cohort of critically ill COVID-19 patients in the United States
-
Prone Positioning and Survival in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Respiratory Failure
-
Questioning the Futility of Cardiopulmonary Resuscitation in Patients With Severe Coronavirus Disease 2019
-
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19
202018 papers
-
Chimeric Antigen Receptor T-Cell Therapy-Associated Cardiomyopathy in Patients With Refractory or Relapsed Non-Hodgkin Lymphoma
-
Clinical and Research Tools for the Study of Cardiovascular Effects of Cancer Therapy
-
COVID-19 and Diabetes: A Collision and Collusion of Two Diseases
-
Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients
-
Ethnic differences in subclinical vascular function in South Asians, Whites, and African Americans in the United States
-
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
-
Implementation of Cardio-Oncology Training for Cardiology Fellows
-
In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study
-
Management of Cardiovascular Disease During Coronavirus Disease (COVID-19) Pandemic
-
Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular Disease
-
Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States
-
Sex Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Adverse Outcomes in Coronary Artery Disease
-
Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia
-
Soluble Urokinase Receptor (SuPAR) in COVID-19–Related AKI
-
Soluble Urokinase Receptor and Acute Kidney Injury
-
Soluble Urokinase Receptor and Acute Kidney Injury. Reply
-
Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease
-
Untargeted high-resolution plasma metabolomic profiling predicts outcomes in patients with coronary artery disease
201911 papers
-
Carcinoid Heart Disease: A Guide for Clinicians
-
Chimeric Antigen Receptor T-Cell Therapy for Cancer and Heart: JACC Council Perspectives
-
How to Say Goodbye: Simple Lessons for the Cardiovascular Physician When Faced With Patient Death
-
Low Educational Attainment is a Predictor of Adverse Outcomes in Patients With Coronary Artery Disease
-
Outcomes From Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis and Left Ventricular Ejection Fraction Less Than 30%: A Substudy From the TOPAS-TAVI Registry
-
Preparing the Cardiovascular Workforce to Care for Oncology Patients: JACC Review Topic of the Week
-
Role of Cardiovascular Biomarkers in the Risk Stratification, Monitoring, and Management of Patients with Cancer
-
Sleep Duration and Mortality in Patients With Coronary Artery Disease
-
Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease
-
uPAR isoform 2 forms a dimer and induces severe kidney disease in mice
-
Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series
201812 papers
-
Cardio-Oncology for GenNext: A Missing Piece of the Training Puzzle
-
Circulating Progenitor Cells and Racial Differences
-
Comparison of the Association Between High-Sensitivity Troponin I and Adverse Cardiovascular Outcomes in Patients With Versus Without Chronic Kidney Disease
-
High-Sensitivity Troponin I Levels and Coronary Artery Disease Severity, Progression, and Long-Term Outcomes
-
Ibrutinib-Associated Atrial Fibrillation
-
Mean Aortic pressure gradient and global longitudinal strain recovery after transcatheter aortic valve replacement - A retrospective analysis
-
Mechanisms Underlying the J-Curve for Diastolic Blood Pressure: Subclinical Myocardial Injury and Immune Activation
-
Oxidative stress predicts cognitive decline with aging in healthy adults: an observational study
-
Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein
-
Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes
-
Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD
-
Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The TOPAS-TAVI Registry
201720 papers
-
2017 Roadmap for Innovation-ACC Health Policy Statement on Healthcare Transformation in the Era of Digital Health, Big Data, and Precision Health
-
A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease
-
Association between oxidative stress and atrial fibrillation
-
Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children
-
Bioactive Lipids and Circulating Progenitor Cells in Patients With Cardiovascular Disease
-
Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease
-
Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study
-
Changes in truncal obesity and fat distribution predict arterial health
-
Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes
-
Cohort profile: the Emory Cardiovascular Biobank (EmCAB)
-
Depression and chest pain in patients with coronary artery disease
-
Effective Information Extraction Framework for Heterogeneous Clinical Reports Using Online Machine Learning and Controlled Vocabularies
-
Flow cytometric data analysis of circulating progenitor cell stability
-
Is it Time to Find a Role for Uric Acid Levels in the Prevention and Management of Hypertension
-
Marital Status and Outcomes in Patients With Cardiovascular Disease
-
Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Comparing Transthoracic versus Transesophageal Echocardiographic Guidance
-
Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death
-
Progenitor Cells and Clinical Outcomes in Patients With Heart Failure
-
Sex Differences in Circulating Progenitor Cells
-
Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis
201612 papers
-
Age and Human Regenerative Capacity Impact of Cardiovascular Risk Factors
-
Anatomic Patterns of Renal Arterial Sympathetic Innervation: New Aspects for Renal Denervation
-
Cardiovascular Magnetic Resonance to Evaluate Aortic Regurgitation After Transcatheter Aortic Valve Replacement
-
Circulating progenitor cells and coronary microvascular dysfunction: Results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD)
-
Circulating Progenitor Cells Identify Peripheral Arterial Disease in Patients With Coronary Artery Disease
-
Effects of a Health-Partner Intervention on Cardiovascular Risk
-
Nitric Oxide Contributes to Vasomotor Tone in Hypertensive African Americans Treated With Nebivolol and Metoprolol
-
Platelets confound the measurement of extracellular miRNA in archived plasma
-
Psychosocial Risk Factors Related to Ischemic Heart Disease in Women
-
Soluble Urokinase Receptor and Chronic Kidney Disease
-
Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease
-
Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease
201514 papers
-
A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity
-
Arrhythmia burden in elderly patients with severe aortic stenosis as determined by continuous electrocardiographic recording: toward a better understanding of arrhythmic events after transcatheter aortic valve replacement
-
Contribution of endothelium-derived hyperpolarizing factor to exercise-induced vasodilation in health and hypercholesterolemia
-
Differential effects of nebivolol and metoprolol on arterial stiffness, circulating progenitor cells, and oxidative stress
-
Dobutamine stress echocardiography for risk stratification of patients with low-gradient severe aortic stenosis undergoing TAVR
-
Echocardiographic and clinical factors related to paravalvular leak incidence in low-gradient severe aortic stenosis patients post-transcatheter aortic valve implantation
-
Effect of storage-aged red blood cell transfusions on endothelial function in healthy subjects
-
Effects of storage-aged red blood cell transfusions on endothelial function in hospitalized patients
-
Infective endocarditis after transcatheter aortic valve implantation: results from a large multicenter registry
-
Low testosterone in men predicts impaired arterial elasticity and microvascular function
-
Provoking Coronary Vasospasm for Diagnosis of Variant Angina: Outdated Trick of the Trade or a Resurgent Diagnostic Modality?
-
Response to Letters Regarding Article, "Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry"
-
Soluble Urokinase Receptor and Chronic Kidney Disease
-
Tumor necrosis factor-alpha antagonism with etanercept improves endothelial progenitor cell counts in patients with psoriasis: etanercept, vascular function and endothelial progenitor cells in psoriasis
201412 papers
-
Assessment of right ventricular function in left ventricular assist device candidates
-
Cardiac magnetic resonance for paravalvular leaks in post-transcatheter aortic valve replacement
-
Differences in vascular nitric oxide and endothelium-derived hyperpolarizing factor bioavailability in blacks and whites
-
Digging deep: high output heart failure in renal cell carcinoma
-
Echocardiographic assessment of pulmonary artery systolic pressure and outcomes in ambulatory heart failure patients
-
End-of-life care planning: improving documentation of advance directives in the outpatient clinic using electronic medical records
-
Endothelium-derived hyperpolarizing factor mediates bradykinin-stimulated tissue plasminogen activator release in humans
-
Incidence and clinical characteristics of takotsubo cardiomyopathy post-aneurysmal subarachnoid hemorrhage
-
Multiparametric Assessment of Post-Transcatheter Aortic Valve Replacement Paravalvular Regurgitation Grading by Transthoracic Echocardiography and Cardiac Magnetic Resonance
-
The role of cardiovascular magnetic resonance in stratifying paravalvular leak severity after transcatheter aortic valve replacement: an observational outcome study
-
Transcatheter valve-in-valve implantation for a degenerated mitral valve bioprosthesis under echocardiographic guidance
-
Transcatheter valve-in-valve implantation for degenerated mitral valve bioprosthesis under 3D echocardiographic guidance
20136 papers
-
Antiretroviral therapy-associated coccidioidal meningitis
-
Atrial myxoma in a patient with hypertrophic cardiomyopathy
-
Effect of progenitor cell mobilization with granulocyte-macrophage colony-stimulating factor in patients with peripheral artery disease: a randomized clinical trial
-
Paravalvular aortic leak after transcatheter aortic valve replacement: current knowledge
-
Prevalence of resistant hypertension and eligibility for catheter-based renal denervation in hypertensive outpatients
-
Rare Elizabethkingia meningosepticum meningitis case in an immunocompetent adult
20112 papers
20081 paper
No publications match those filters.